156 related articles for article (PubMed ID: 21607840)
1. Pancreatic cancer screening employing noncontrast magnetic resonance imaging combined with ultrasonography.
Kuroki-Suzuki S; Kuroki Y; Nasu K; Nagashima C; Machida M; Muramatsu Y; Moriyama N
Jpn J Radiol; 2011 May; 29(4):265-71. PubMed ID: 21607840
[TBL] [Abstract][Full Text] [Related]
2. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
3. Real-world Evidence of Diffusion-weighted Imaging Combined With Magnetic Resonance Cholangiopancreatography for Pancreatic Tumor Screening: A Cross-Sectional Diagnostic Accuracy Study.
Fukuba N; Ishitobi H; Takahashi Y; Nagaoka M; Fukuhara H; Yuki M; Komazawa Y; Kuroda H; Sato S; Shizuku T
Pancreas; 2020 Oct; 49(9):1182-1186. PubMed ID: 32898002
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional contrast-enhanced ultrasonography of intraductal papillary mucinous neoplasms of the pancreas: a comparison with magnetic resonance imaging.
Pezzilli R; Serra C; Calculli L; Ferroni F; Iammarino MT; Casadei R
Pancreas; 2013 Oct; 42(7):1164-8. PubMed ID: 23770711
[TBL] [Abstract][Full Text] [Related]
5. Role of abdominal ultrasound for the surveillance follow-up of pancreatic cystic neoplasms: a cost-effective safe alternative to the routine use of magnetic resonance imaging.
Morelli L; Guadagni S; Borrelli V; Pisano R; Di Franco G; Palmeri M; Furbetta N; Gambaccini D; Marchi S; Boraschi P; Bastiani L; Campatelli A; Mosca F; Di Candio G
World J Gastroenterol; 2019 May; 25(18):2217-2228. PubMed ID: 31143072
[TBL] [Abstract][Full Text] [Related]
6. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of rapid MR pancreas screening for patients with BRCA mutation.
Corrias G; Raeside MC; Agostini A; Huicochea-Castellanos S; Aramburu-Nunez D; Paudyal R; Shukla-Dave A; Smelianskaia O; Capanu M; Zheng J; Fung M; Kelsen DP; Mangino DA; Robson ME; Goldfrank DJ; Carter J; Allen PJ; Conti B; Monti S; Do RKG; Mannelli L
Eur Radiol; 2019 Aug; 29(8):3976-3985. PubMed ID: 30689033
[TBL] [Abstract][Full Text] [Related]
8. Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.
Del Chiaro M; Verbeke CS; Kartalis N; Pozzi Mucelli R; Gustafsson P; Hansson J; Haas SL; Segersvärd R; Andren-Sandberg Å; Löhr JM
JAMA Surg; 2015 Jun; 150(6):512-8. PubMed ID: 25853369
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.
Verna EC; Hwang C; Stevens PD; Rotterdam H; Stavropoulos SN; Sy CD; Prince MA; Chung WK; Fine RL; Chabot JA; Frucht H
Clin Cancer Res; 2010 Oct; 16(20):5028-37. PubMed ID: 20876795
[TBL] [Abstract][Full Text] [Related]
10. Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas.
Hwang J; Kim YK; Min JH; Jeong WK; Hong SS; Kim HJ
Eur Radiol; 2018 Jan; 28(1):179-187. PubMed ID: 28779397
[TBL] [Abstract][Full Text] [Related]
11. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
[TBL] [Abstract][Full Text] [Related]
13. MRI Combined with Magnetic Resonance Cholangiopancreatography for Diagnosis of Benign and Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms.
Liu X; Xu W; Liu Z; Ye J
Curr Med Imaging Rev; 2019; 15(5):504-510. PubMed ID: 32008558
[TBL] [Abstract][Full Text] [Related]
14. Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts.
Sainani NI; Saokar A; Deshpande V; Fernández-del Castillo C; Hahn P; Sahani DV
AJR Am J Roentgenol; 2009 Sep; 193(3):722-31. PubMed ID: 19696285
[TBL] [Abstract][Full Text] [Related]
15. Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm.
Kang HJ; Lee DH; Lee JM; Yoo J; Weiland E; Kim E; Son Y
Invest Radiol; 2020 May; 55(5):262-269. PubMed ID: 32073419
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI in the characterization of cystic pancreatic lesions: usefulness of ADC values.
Boraschi P; Donati F; Gigoni R; Salemi S; Bartolozzi C; Falaschi F
Magn Reson Imaging; 2010 Dec; 28(10):1447-55. PubMed ID: 20864287
[TBL] [Abstract][Full Text] [Related]
17. MR imaging and MR cholangiopancreatography of multifocal intraductal papillary mucinous neoplasms of the side branches: MR pattern and its evolution.
Manfredi R; Mehrabi S; Motton M; Graziani R; Ferrari M; Salvia R; Pozzi Mucelli R
Radiol Med; 2008 Apr; 113(3):414-28. PubMed ID: 18493777
[TBL] [Abstract][Full Text] [Related]
18. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings.
Pilleul F; Rochette A; Partensky C; Scoazec JY; Bernard P; Valette PJ
J Magn Reson Imaging; 2005 Mar; 21(3):237-44. PubMed ID: 15723374
[TBL] [Abstract][Full Text] [Related]
19. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
Canto MI; Hruban RH; Fishman EK; Kamel IR; Schulick R; Zhang Z; Topazian M; Takahashi N; Fletcher J; Petersen G; Klein AP; Axilbund J; Griffin C; Syngal S; Saltzman JR; Mortele KJ; Lee J; Tamm E; Vikram R; Bhosale P; Margolis D; Farrell J; Goggins M;
Gastroenterology; 2012 Apr; 142(4):796-804; quiz e14-5. PubMed ID: 22245846
[TBL] [Abstract][Full Text] [Related]
20. MRI of the Pancreas.
Harrington KA; Shukla-Dave A; Paudyal R; Do RKG
J Magn Reson Imaging; 2021 Feb; 53(2):347-359. PubMed ID: 32302044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
